Compare Cytokinetics Inc (CYTK) vs EPR Properties (EPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs EPR Properties — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while EPR Properties trades at $59.8 (market cap $4.58B). The key difference: Cytokinetics Inc is far larger — about 2.3× EPR Properties's market cap, and EPR Properties pays a 6.22% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | EPR | |
|---|---|---|
Market Cap | $10.63B | $4.58B |
Sector | Technology | Real Estate |
52-Week High | $87.26 | $64.32 |
52-Week Low | $34.31 | $48.71 |
Enterprise Value | $10.74B | $8.09B |
Dividend Yield | — | 6.22% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →
